Emzumab 150Mg Combikit Dry Vial Of 1 Powder For Injection
1 Powder For Injection(s) in Dry VialMRP ₹13975.50
₹11879.17
15% OFF
Made by
CIPLA LIMITED
Dosage
POWDER FOR INJECTION
Expiry
Product Summary
| Uses | Allergic asthma |
| Therapy | Anti-asthmatic |
| Side effects | Injection-site reaction, Headache, Joint pain, Fever |
| Salt Content | Omalizumab(150.0 Mg) |
Assurance
available
Regulated
Medical Description
Emzumab powder for injection is used for allergic asthma. Its active ingredient is omalizumab.
Uses
- Allergic asthma
Contraindications
Side effects
- Injection-site reaction
- Headache
- Joint pain
- Fever
Precautions and Warnings
Pregnancy
Breast Feeding
Alcohol
Driving
Other General Warnings
- Have previously had a serious allergic reaction to omalizumab or any ingredients in the powder formulation.
- Develop sudden breathing difficulty, severe throat tightness, chest discomfort, or swelling in your face or limbs.
- Are at high risk for parasitic (helminth) infections due to travel or your area, as treatment will be adjusted.
- Have a history of severe allergic reactions or anaphylaxis.
- Notice worsening asthma symptoms or an increased need for short-acting inhalers after starting treatment.
- Have a personal or strong family history of cancer, so your doctor can discuss this alongside the medicine's benefits.
- Have a food allergy and are relying on Emzumab powder for injection — remember it reduces risk but does not replace food avoidance or emergency treatment for a reaction.
Directions for Use
Storage and disposal
Quick Tips
- This medicine does not replace a rescue inhaler for a sudden asthma attack.
- Seek emergency help for breathing difficulty, throat or tongue swelling, faintness or widespread hives after an injection.
Dosage
Missed a Dose
Overdose
How does this medicine work?
Interactions
Interactions with other medicines
Interactions with food items
Frequently Asked Questions (FAQs)
References:
- Central Drugs Standard Control Organisation (CDSCO)
- U.S. Food and Drug Administration (FDA) - Xolair (Omalizumab) Prescribing Information
- European Medicines Agency (EMA) - Xolair (Omalizumab) Summary of Product Characteristics
- https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d
- https://www.medscape.com/viewarticle/fda-approves-omalizumab-multiple-food-allergy-2024a10003sf
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:EMZUMAB
Manufacturer Name:CIPLA LIMITED
Address:<p>1. Reliance Life Sciences Pvt Ltd. Plant 2, R282, Ttc Area Of Midc Rabale, Thane, Belapur Road, Navi Mumbai. Mahrashtra India -400701</p>
Country of Origin:India
Vendor Details
Fulfillment Information: Emzumab 150 MG Powder For Injection (1) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.






















